Literature DB >> 14724819

Screening for Barrett's esophagus in colonoscopy patients with and without heartburn.

Douglas K Rex1, Oscar W Cummings, Michael Shaw, Mark D Cumings, Roy K H Wong, Raj S Vasudeva, Donal Dunne, Emad Y Rahmani, Debra J Helper.   

Abstract

BACKGROUND & AIMS: The population prevalence of Barrett's esophagus (BE) is uncertain. Our aim was to describe the prevalence of BE in a volunteer population.
METHODS: Upper endoscopy (EGD) was performed in 961 persons with no prior history of EGD who were scheduled for colonoscopy. Symptom questionnaires were completed prior to endoscopy. Biopsy specimens were taken from the gastric cardia and any columnar mucosa extending > or =5 mm into the tubular esophagus and from the stomach for H. pylori infection in the last 812 patients.
RESULTS: The study sample was biased toward persons undergoing colonoscopy, males, and persons with upper GI symptoms. The prevalence of BE was 65 of 961 (6.8%) patients, including 12 (1.2%) with long-segment BE (LSBE). Among 556 subjects who had never had heartburn, the prevalences of BE and LSBE were 5.6% and 0.36%, respectively. Among 384 subjects with a history of any heartburn, the prevalences of BE and LSBE were 8.3% and 2.6%, respectively. In a univariate analysis, LSBE was more common in those with any heartburn vs. those with no heartburn (P = 0.01), but the sample size was insufficient to allow multivariate analysis of predictors of LSBE. In a multivariate analysis, BE was associated with increasing age (P = 0.02), white race (P = 0.03), and negative H. pylori status (P = 0.04). Overall, BE was not associated with heartburn, although heartburn was more common in persons with LSBE or circumferential short segments.
CONCLUSIONS: LSBE is very uncommon in patients who have no history of heartburn. SSBE is relatively common in persons age > or =40 years with no prior endoscopy, irrespective of heartburn history.

Entities:  

Mesh:

Year:  2003        PMID: 14724819     DOI: 10.1053/j.gastro.2003.09.030

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  139 in total

1.  Biomarkers in exploring the frontiers of diagnosis, prognosis, and therapy of Barrett's esophagus.

Authors:  Patrick Yachimski; Richard M Peek
Journal:  Cancer Prev Res (Phila)       Date:  2011-06

2.  The impact of obesity on the rise in esophageal adenocarcinoma incidence: estimates from a disease simulation model.

Authors:  Chung Yin Kong; Kevin J Nattinger; Tristan J Hayeck; Zehra B Omer; Y Claire Wang; Stuart J Spechler; Pamela M McMahon; G Scott Gazelle; Chin Hur
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-09-19       Impact factor: 4.254

Review 3.  [Barrett's esophagus. An update].

Authors:  G B Baretton; D E Aust
Journal:  Pathologe       Date:  2012-02       Impact factor: 1.011

4.  Barrett's Esophagus: A Review of Biology and Therapeutic Approaches.

Authors:  Panteleimon Kountourakis; Jaffer A Ajani; Marta Davila; Jeffrey H Lee; Manoop S Bhutani; Julie G Izzo
Journal:  Gastrointest Cancer Res       Date:  2012-03

5.  Biodegradable esophageal stent placement does not prevent high-grade stricture formation after circumferential mucosal resection in a porcine model.

Authors:  Eric M Pauli; Steve J Schomisch; Joseph P Furlan; Andrea S Marks; Amitabh Chak; Richard H Lash; Jeffrey L Ponsky; Jeffrey M Marks
Journal:  Surg Endosc       Date:  2012-06-09       Impact factor: 4.584

Review 6.  Guidelines for surgical treatment of gastroesophageal reflux disease.

Authors:  Dimitrios Stefanidis; William W Hope; Geoffrey P Kohn; Patrick R Reardon; William S Richardson; Robert D Fanelli
Journal:  Surg Endosc       Date:  2010-08-20       Impact factor: 4.584

Review 7.  Barrett's esophagus: Clinical issues.

Authors:  Stuart Jon Spechler
Journal:  Gastrointest Endosc Clin N Am       Date:  2011-01

8.  Chemoprevention of esophageal adenocarcinoma.

Authors:  Julian A Abrams
Journal:  Therap Adv Gastroenterol       Date:  2008-07       Impact factor: 4.409

9.  Are We Making Progress in Preventing Barrett's-Related Esophageal Cancer?

Authors:  Julian A Abrams
Journal:  Therap Adv Gastroenterol       Date:  2009-03       Impact factor: 4.409

10.  A randomized comparative effectiveness trial of novel endoscopic techniques and approaches for Barrett's esophagus screening in the community.

Authors:  Sarmed S Sami; Kelly T Dunagan; Michele L Johnson; Cathy D Schleck; Nilay D Shah; Alan R Zinsmeister; Louis-Michel Wongkeesong; Kenneth K Wang; David A Katzka; Krish Ragunath; Prasad G Iyer
Journal:  Am J Gastroenterol       Date:  2014-12-09       Impact factor: 10.864

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.